2017 Q2 Form 10-Q Financial Statement

#000156459017016927 Filed on August 09, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q4 2016 Q2
Revenue $4.782M $5.870M $3.960M
YoY Change 20.76% -24.65% 12.18%
Cost Of Revenue $1.680M $2.090M $1.050M
YoY Change 60.0% -52.61% -3.67%
Gross Profit $3.110M $3.780M $2.910M
YoY Change 6.87% 11.83% 18.78%
Gross Profit Margin 65.04% 64.4% 73.48%
Selling, General & Admin $3.000M $3.070M $3.064M
YoY Change -2.09% -19.63% 0.2%
% of Gross Profit 96.46% 81.22% 105.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.00K $80.00K $80.00K
YoY Change 0.0% -11.11% -50.0%
% of Gross Profit 2.57% 2.12% 2.75%
Operating Expenses $3.080M $3.150M $3.064M
YoY Change 0.52% -19.23% 0.2%
Operating Profit $30.00K $630.0K -$234.0K
YoY Change -112.82% -221.15% -65.07%
Interest Expense -$30.00K -$30.00K $63.00K
YoY Change -147.62% -120.0% 3.28%
% of Operating Profit -100.0% -4.76%
Other Income/Expense, Net -$180.0K -$910.0K -$2.000K
YoY Change 8900.0% -403.33%
Pretax Income -$184.0K -$310.0K $626.0K
YoY Change -129.39% -94.37% -190.33%
Income Tax $15.00K -$10.00K $2.000K
% Of Pretax Income 0.32%
Net Earnings -$199.0K -$300.0K $624.0K
YoY Change -131.89% -94.55% -190.04%
Net Earnings / Revenue -4.16% -5.11% 15.76%
Basic Earnings Per Share -$0.01 $0.02
Diluted Earnings Per Share -$0.01 -$10.55K $0.02
COMMON SHARES
Basic Shares Outstanding 28.48M 28.51M 28.42M
Diluted Shares Outstanding 28.48M 28.43M

Balance Sheet

Concept 2017 Q2 2016 Q4 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.600M $2.530M $2.040M
YoY Change 27.45% -8.99% -28.42%
Cash & Equivalents $2.600M $2.530M $2.040M
Short-Term Investments
Other Short-Term Assets $370.0K $390.0K $480.0K
YoY Change -22.92% -13.33% -2.04%
Inventory $260.0K $263.0K $301.0K
Prepaid Expenses
Receivables $1.140M $1.250M $700.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.370M $4.433M $7.244M
YoY Change -39.67% 3.96% 77.99%
LONG-TERM ASSETS
Property, Plant & Equipment $120.0K $156.0K $160.0K
YoY Change -25.0% 41.82% 23.08%
Goodwill $6.158M
YoY Change 0.0%
Intangibles $4.122M
YoY Change -5.93%
Long-Term Investments
YoY Change
Other Assets $310.0K $275.0K $270.0K
YoY Change 14.81% 58.96% -95.85%
Total Long-Term Assets $10.59M $10.71M $10.84M
YoY Change -2.27% -26.32% -53.45%
TOTAL ASSETS
Total Short-Term Assets $4.370M $4.433M $7.244M
Total Long-Term Assets $10.59M $10.71M $10.84M
Total Assets $14.96M $15.14M $18.08M
YoY Change -17.26% -19.46% -33.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.940M $6.750M $6.480M
YoY Change 7.1% 1.2% 15.92%
Accrued Expenses $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $500.0K $660.0K $4.250M
YoY Change -88.24% -61.63% 3.66%
Total Short-Term Liabilities $8.047M $8.570M $11.20M
YoY Change -28.15% -8.4% 9.8%
LONG-TERM LIABILITIES
Long-Term Debt $120.0K $350.0K $0.00
YoY Change -86.0%
Other Long-Term Liabilities $2.160M $1.770M $1.790M
YoY Change 20.67% -31.66% -52.14%
Total Long-Term Liabilities $2.280M $2.120M $1.790M
YoY Change 27.37% -58.35% -52.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.047M $8.570M $11.20M
Total Long-Term Liabilities $2.280M $2.120M $1.790M
Total Liabilities $11.29M $11.65M $13.94M
YoY Change -19.05% -24.39% -6.44%
SHAREHOLDERS EQUITY
Retained Earnings -$280.8M -$280.9M
YoY Change 0.0%
Common Stock $285.0K $285.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.679M $3.494M $4.130M
YoY Change
Total Liabilities & Shareholders Equity $14.96M $15.14M $18.08M
YoY Change -17.23% -19.46% -33.89%

Cashflow Statement

Concept 2017 Q2 2016 Q4 2016 Q2
OPERATING ACTIVITIES
Net Income -$199.0K -$300.0K $624.0K
YoY Change -131.89% -94.55% -190.04%
Depreciation, Depletion And Amortization $80.00K $80.00K $80.00K
YoY Change 0.0% -11.11% -50.0%
Cash From Operating Activities -$680.0K -$60.00K $1.180M
YoY Change -157.63% -700.0% -221.65%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K -$80.00K
YoY Change -100.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $20.00K
YoY Change -100.0% -100.0% -95.45%
Cash From Investing Activities $0.00 -$10.00K -$60.00K
YoY Change -100.0% -110.0% -113.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -560.0K -740.0K -400.0K
YoY Change 40.0% -31.03%
NET CHANGE
Cash From Operating Activities -680.0K -60.00K 1.180M
Cash From Investing Activities 0.000 -10.00K -60.00K
Cash From Financing Activities -560.0K -740.0K -400.0K
Net Change In Cash -1.240M -810.0K 720.0K
YoY Change -272.22% -836.36% -164.86%
FREE CASH FLOW
Cash From Operating Activities -$680.0K -$60.00K $1.180M
Capital Expenditures $0.00 -$10.00K -$80.00K
Free Cash Flow -$680.0K -$50.00K $1.260M
YoY Change -153.97% -350.0% -229.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
348000
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
961000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
145000
CY2017Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2158000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
199000
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1772000
CY2016Q4 us-gaap Liabilities
Liabilities
11650000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3494000
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
857000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
626000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
702000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28456750
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
285000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-71000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
3679000
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
960000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
71000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
285000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15144000
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
284282000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
284149000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
36000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14964000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
960000
CY2017Q2 us-gaap Liabilities
Liabilities
11285000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
624000
us-gaap Net Income Loss
NetIncomeLoss
55000
us-gaap Income Taxes Paid
IncomeTaxesPaid
16000
us-gaap Income Taxes Paid
IncomeTaxesPaid
19000
us-gaap Interest Paid
InterestPaid
2000
us-gaap Interest Paid
InterestPaid
94000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8570000
CY2017Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
120000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
404000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
428000
hgbl Payment Of Contingent Consideration
PaymentOfContingentConsideration
400000
hgbl Payment Of Contingent Consideration
PaymentOfContingentConsideration
400000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-814000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-420000
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
70000
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-737000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2777000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2040000
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3000
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-201000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
627000
CY2016Q2 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
925000
us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-290000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-199000
CY2017Q2 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-179000
CY2017Q2 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
32000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
83000
CY2016Q2 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
65000
hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
47000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-184000
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28480148
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28418582
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28431406
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Operating Income Loss
OperatingIncomeLoss
420000
us-gaap Operating Income Loss
OperatingIncomeLoss
-42000
us-gaap Share Based Compensation
ShareBasedCompensation
132000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
195000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-297000
us-gaap Share Based Compensation
ShareBasedCompensation
57000
us-gaap Net Income Loss
NetIncomeLoss
684000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
132000
hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
113000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8047000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280820000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280875000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-74000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28381278
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
679000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28472910
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
415000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28368774
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28480148
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
20000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
48000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
884000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-262000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
20000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
75000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-55000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12504
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2200000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2200000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016Q4 us-gaap Loans Payable
LoansPayable
1012000
CY2016Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
44000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
125000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates include the assessment of collectability of revenue recognized, and the valuation of accounts receivable, inventory, other assets, goodwill and intangible assets, liabilities, contingent consideration, deferred income tax assets and liabilities, and stock-based compensation. These estimates have the potential to significantly impact the Company&#8217;s consolidated financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.</p></div>
CY2017Q2 us-gaap Liabilities Fair Value Disclosure Nonrecurring
LiabilitiesFairValueDisclosureNonrecurring
0
CY2017Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
74500000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Certain prior year balances within the condensed consolidated financial statements have been reclassified to conform to the current year presentation.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical accounting policies used in the preparation of the Company&#8217;s audited consolidated financial statements are discussed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016. There have been no changes to these policies in the six months ended June 30, 2017.</p></div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10350
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5169200
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5198850
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1912500
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.96
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.48
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.08
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.45
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.95
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.82
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
37500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
37500
CY2017Q2 hgbl Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Vested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedNumber
262500
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.38
CY2017Q2 hgbl Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
0.38
us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
The Company’s Class N preferred shares, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock.
CY2017Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
40
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12824
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16160
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5100000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1685000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
123000
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1562000
CY2017Q2 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
500000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
122000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
245000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
240000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
236000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
236000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
483000
CY2017Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017Q2 us-gaap Loans Payable
LoansPayable
616000
CY2017Q2 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
0
hgbl Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
Substantially all of the net operating loss carry forwards and unused minimum tax credit carry forwards expire between 2024 and 2035.
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The Company’s utilization of restricted net operating tax loss carry forwards against future income for tax purposes is restricted pursuant to the “change in ownership” rules in Section 382 of the Internal Revenue Code.
CY2017Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
25000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
50000

Files In Submission

Name View Source Status
0001564590-17-016927-index-headers.html Edgar Link pending
0001564590-17-016927-index.html Edgar Link pending
0001564590-17-016927.txt Edgar Link pending
0001564590-17-016927-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201708091556005313234.jpg Edgar Link pending
hgbl-10q_20170630.htm Edgar Link pending
hgbl-20170630.xml Edgar Link completed
hgbl-20170630.xsd Edgar Link pending
hgbl-20170630_cal.xml Edgar Link unprocessable
hgbl-20170630_def.xml Edgar Link unprocessable
hgbl-20170630_lab.xml Edgar Link unprocessable
hgbl-20170630_pre.xml Edgar Link unprocessable
hgbl-ex311_7.htm Edgar Link pending
hgbl-ex312_6.htm Edgar Link pending
hgbl-ex321_9.htm Edgar Link pending
hgbl-ex322_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending